&. Mamounas and E. P. , Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: A National Cancer Institute conference, 2008.

B. S. , C. B. , F. A. , G. S. Hennequin-c, . M. Leblanc-onfroy et al., Radiotherapy of invasive breast cancer: French national guidelines, Cancer/Radiothérapie, vol.16, pp.503-513, 2012.

D. S. Mcgale-p, T. C. Correa-c, A. R. , C. M. , C. D. Davies-c et al., Early Breast Cancer Trialists' Collaborative Group (EBCTCG). 2011. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials, Lancet, vol.378, pp.1707-1716

M. P. , T. C. Correa-c, C. D. , D. F. Ewertz-m, G. R. Mannu-g et al., Early Breast Cancer Trialists

C. Group, Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomized trials, Lancet, issue.9935, pp.383-2127, 2014.

&. Hortobagyi and G. N. , Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation, J Clin Oncol, vol.20, issue.1, pp.17-23, 2002.

G. A. Strom-e, . D. Mcneese-m, . U. Buzdar-a, K. N. Hortobagyi-g, . H. Perkins-g et al., T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy, Int J Radiat Oncol Biol Phys, vol.59, issue.1, pp.138-145, 2004.

H. E. , T. S. Strom-e, K. D. Mcneese-m, . N. Hortobagyi-g, . U. Buzdar-a et al., Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy, Int J Radiat Oncol Biol Phys, vol.62, issue.2, pp.351-357, 2005.

M. E. Buchholz-t, T. S. Meric-bernstam, K. H. Gonzalez-angulo-a, . Bedrosian-i, . V. Babiera-g et al., Impact of chemotherapy sequencing on localregional failure risk in breast cancer patients undergoing breast-conserving therapy, Ann Surg, vol.257, issue.2, pp.173-179, 2013.

W. J. Takita-c, . M. Reis-i, . Zhao-w, . Saigal-k, M. A. Wolfson-a et al., Predictors of locoregional outcome in patients receiving neoadjuvant therapy and post mastectomy radiation, Cancer, vol.119, issue.1, pp.16-25, 2013.

S. S. , V. J. , T. S. Bedrosian-i, L. F. Shaitelman-s, S. B. Caudle-a et al., Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy, Ann Surg Oncol, vol.23, issue.3, pp.749-756, 2016.

J. E. , S. K. , K. J. , P. Y. , J. et al., Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment, Cancer Res Treat, 2016.

W. N. , W. J. Mamounas-e, and B. J. Fisher-b, Preoperative Chemotherapy in Patients with Operable Breast Cancer: Nine-Year Results from National Surgical Adjuvant Breast and Bowel Project B-18, J Natl Cancer Inst Monogr, vol.30, pp.96-102, 2001.

B. H. , A. S. , S. R. Geyer-c, . Jr, . P. Mamounas-e et al., Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27, J Clin Oncol, vol.24, pp.2019-2027, 2006.

T. A. Jr and W. D. Wolmark-n, Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27, J Clin Oncol, issue.32, pp.30-3960, 2012.

H. C. Barlow-w, G. P. Costantino-j, C. I. Pritchard-k, S. J. Hunsberger-s, . A. Enos-r et al., Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system, J Clin Oncol, issue.15, pp.25-2127, 2007.

G. A. , W. W. Coates-a, . D. Gelber-r, . Thurlimann-b, . J. Senn-h et al., Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, Ann Oncol, vol.22, pp.1736-1747, 2011.

H. E. , T. S. Strom-e, K. D. Mcneese-m, . U. Buzdar-a, . Valero-v et al., Post mastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy, J Clin Oncol, issue.23, pp.22-4691, 2004.

M. S. Gonzalez-angulo-a, T. H. Huang-e, . Kau-s-w, . Yu-t-k, O. A. Strom-e et al., Post mastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy, Int J Radiat Oncol Biol Phys, vol.68, issue.4, pp.1004-1009, 2007.

N. H. , M. E. Strom-e, O. H. Perkins-g, T. W. Woodward-w, H. M. Gonzalez-angulo-a et al., Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer, Int J Radiat Oncol Biol Phys, vol.81, issue.3, pp.782-787, 2011.

G. L. Dafni-u, A. D. Gelber-r, M. S. , G. A. , U. M. et al., Herceptin Adjuvant (HERA) Trial Study Team Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4- year follow-up of a randomised controlled trial, Lancet Oncol, vol.12, pp.236-244, 2011.

B. H. , L. S. Piccart-m, . Macgrogan-g, B. E. Fumoleau-p, R. P. Petit-t et al., Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step, Ann Oncol, vol.25, pp.1128-1136

A. C. Meric-bernstam, H. K. Grubbs-e, T. S. Bedrosian-i, K. H. Hoffman-k, . V. Babiera-g et al., Evaluation of the MD Anderson Prognostic Index for localregional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy, Ann Surg Oncol, vol.19, issue.3, pp.901-907, 2012.

B. , C. C. Bleuse-a, C. I. , and C. C. Largillier-r, Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI, Breast Cancer Res Treat, vol.72, issue.2, pp.145-152, 2002.

B. H. Horiot-j-c, . M. Poortmans-p, . Struikmans-h, F. W. Van-den-bogaert, . J. Jager-j et al., Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial, J Clin Oncol, issue.22, pp.25-3259, 2007.

B. H. Maingon-p, . Poortmans-p, F. A. Weltens-c, J. J. , S. D. Oei-b et al., European Organization for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. 2015. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomized phase III trial, Lancet Oncol, vol.16, issue.1, pp.47-56

B. H. , A. S. , S. R. Geyer-c, . Jr, . P. Mamounas-e et al., Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27, J Clin Oncol, vol.24, pp.2019-2027, 2006.

B. J. , J. P. , and G. B. Nygren-p, SBU-group. Swedish Council of Technology Assessment in Health Care A systematic overview of chemotherapy effects in breast cancer, Acta Oncol, vol.40, pp.253-281, 2001.

B. A. Amoroso-v, . Gallo-f, . Bertaglia-v, . Simoncini-e, . Pedersini-r et al., Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies, J Clin Oncol, vol.32, pp.3883-3891, 2014.

B. S. , C. B. , F. A. , G. S. Hennequin-c, . M. Leblanc-onfroy et al., Radiotherapy of invasive breast cancer: French national guidelines, Cancer/Radiothérapie, vol.16, pp.503-513, 2012.

B. Poirier-b, . Basik-m, . M. Holloway-c, . Gaboury-l, . Sideris-l et al., Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study, J Clin Oncol, vol.33, issue.3, pp.258-264, 2015.

B. H. , L. S. Piccart-m, . Macgrogan-g, B. E. Fumoleau-p, R. P. Petit-t et al., Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step, Ann Oncol, vol.25, pp.1128-1136

B. J. Suman-v, M. E. , A. G. Wilke-l, . Taback-b, K. M. Leitch-a et al., Alliance for Clinical Trials in Oncology, Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial, pp.310-1455, 2013.

B. E. Nistico-c, C. F. , C. P. , C. M. Milella-m, . Natoli-g et al., Benefit of taxanes as adjuvant chemotherapy for early breast cancer: pooled analysis of 15,500 patients, Cancer, vol.106, pp.2337-2344, 2006.

B. T. , H. K. , W. G. Sahin-a, and . N. Hortobagyi-g, Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks, Cancer, issue.6, pp.98-1150, 2003.

B. T. Lehman-c, H. J. , P. B. Khouri-n, . F. Hylton-n, . J. Miller-m et al., Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: A National Cancer Institute conference, J Clin Oncol, vol.26, issue.5, pp.791-797, 2008.

B. T. , T. S. Masullo-l, K. H. , E. J. Salas-j, . Frye-d et al., Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation, J Clin Oncol, vol.20, issue.1, pp.17-23, 2002.

B. W. Bölke-e, . Kammers-k, . A. Gerber-p, . Nestle-krämling-c, and . Matuschek-c, Adjuvant radiation therapy of regional lymph nodes in breast cancer -a meta-analysis of randomized trials-an update, Radiat Oncol, vol.10, p.258, 2015.

C. A. , Y. , T. S. Bedrosian-i, L. J. Gonzalez-angulo-a, . Hoffman-k et al., Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy, Breast Cancer Res, vol.14, issue.3, p.83, 2012.

C. A. Meric-bernstam, H. K. Thames-h, O. M. Outlaw-e, . A. Strom-e, K. D. Mcneese-m et al., Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience, J Clin Oncol, issue.12, pp.22-2303, 2004.

C. B. Fumoleau-p, . Kerbrat-p, . Dieras-v, . Roche-h, A. N. Krakowski-i et al., Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer, J Clin Oncol, vol.13, pp.314-322, 1995.

C. A. Winer-e, G. A. Gelber-r, . Gnant-m, . Piccart-gebhart-m, and S. Thürlimann-b, Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015, Ann Oncol, issue.8, pp.26-1533, 2015.

D. S. Mcgale-p, T. C. Correa-c, A. R. , C. M. , C. D. Davies-c et al., Early Breast Cancer Trialists' Collaborative Group (EBCTCG). 2011. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials, Lancet, vol.378, pp.1707-1716

D. C. Stevens-d, B. E. Berges-o, . Villette-s, G. M. Moisson-p, L. S. De-la-lande-b et al., Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy, Int J Radiat Oncol Biol Phys, vol.78, issue.2, pp.337-342, 2010.

D. Vogel-cl, Management of locally advanced breast cancer (stage III): a review, Int Adv Surg Oncol, vol.7, pp.297-327, 1984.

D. Angelis, R. Sant-m, C. M. , F. S. Baili-p, T. A. Pierannunzio-d et al., Cancer survival in Europe 1999???2007 by country and age: results of EUROCARE-5???a population-based study, The Lancet Oncology, vol.15, issue.1, pp.23-34, 2014.
DOI : 10.1016/S1470-2045(13)70546-1

F. T. Wilcken-n, G. D. Vagg-r, and . K. Nowak-a, Taxanes for adjuvant treatment of early breast cancer, Cochrane Database Syst Rev, issue.4, p.4421, 2007.

F. E. , W. J. , B. J. Fisher-b, and M. E. Wolmark-n, Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18, Cancer, vol.95, pp.681-695, 2002.

F. B. , E. J. , K. D. Mccloskey-s, M. J. , Y. C. et al., Athena Breast Health Network. 2012. Role of post mastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer, Int J Radiat Oncol Biol Phys, vol.83, issue.2, pp.494-503

F. Chen-h-l, Y. J. Yi-c-h, and . Zheng-s, Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis, PLoS One, vol.9, issue.9, p.105316, 2014.

G. A. Buchholz-t, Influence of neoadjuvant chemotherapy on radiotherapy for breast cancer, Ann Surg Oncol, vol.22, issue.5, pp.1434-1440, 2015.

G. A. Strom-e, . D. Mcneese-m, . U. Buzdar-a, K. N. Hortobagyi-g, . H. Perkins-g et al., T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy, Int J Radiat Oncol Biol Phys, vol.59, issue.1, pp.138-145, 2004.

G. D. and W. N. Simes-r, A systematic review of taxane-containing regimens for metastatic breast cancer, Br J Cancer, vol.93, pp.293-301, 2005.

G. L. Dafni-u, A. D. Gelber-r, M. S. , G. A. , U. M. et al., Herceptin Adjuvant (HERA) Trial Study Team Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial, Lancet Oncol, vol.12, pp.236-244, 2011.

G. L. Eiermann-w, L. A. Semiglazov-v, . Tjulandin-s, M. A. Zambetti-m, . Vazquez-f et al., Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomized controlled superiority trial with a parallel HER2-negative cohort, Lancet Oncol, vol.15, pp.640-647, 2014.

G. O. Durando-x, A. C. Bellière-a, . Gimbergues-p, . Thivat-e, . Planchat-e et al., Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?, Cancer Invest, vol.28, issue.2, pp.195-200, 2010.

G. A. Winer-e, . S. Coates-a, . D. Gelber-r, T. B. Piccart-gebhart-m, and . J. Senn-h, Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013, Ann Oncol, vol.24, pp.2206-2223, 2013.

G. A. , W. W. Coates-a, . D. Gelber-r, . Thurlimann-b, . J. Senn-h et al., Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, Ann Oncol, vol.22, pp.1736-1747, 2011.

H. I. , B. D. , D. G. , C. C. Goldstein-l, M. S. Ingle-j et al., Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer, J Clin Oncol, vol.21, pp.976-983, 2003.

H. C. Bossard-n, . S. Servagi-vernat, D. Maingon-p, D. J. , C. C. et al., Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy, 2013.

H. N. Macaskill-p, M. G. Von, and . Mamounas-e, Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy, Eur J Cancer, vol.48, pp.3342-3354, 2012.

H. E. Strom-e, O. H. Perkins-g, C. A. Meric-bernstam, H. K. Sahin-a, . N. Hortobagyi-g et al., Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score, Int J Radiat Oncol Biol Phys, vol.66, issue.2, pp.352-357, 2006.

H. E. , T. S. Strom-e, K. D. Mcneese-m, . U. Buzdar-a, . Valero-v et al., Post mastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy, J Clin Oncol, issue.23, pp.22-4691, 2004.

H. E. , T. S. Strom-e, K. D. Mcneese-m, . N. Hortobagyi-g, . U. Buzdar-a et al., Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy, Int J Radiat Oncol Biol Phys, vol.62, issue.2, pp.351-357, 2005.

H. C. Barlow-w, G. P. Costantino-j, C. I. Pritchard-k, S. J. Hunsberger-s, . A. Enos-r et al., Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system, J Clin Oncol, issue.15, pp.25-2127, 2007.

J. J. Jones-s, C. C. Magne-n, E. P. , J. W. , M. D. et al., Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials, Breast Cancer Res Treat, vol.134, pp.903-913, 2011.

J. E. , S. K. , K. J. , P. Y. , J. et al., Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment, Cancer Res Treat, 2016.

K. A. Strom-e, . A. Buchholz-t, S. D. Thames-h, J. A. Hortobagyi-g, . U. Buzdar-a et al., Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation, J Clin Oncol, issue.15, pp.18-2817, 2000.

K. A. Strom-e, . A. Buchholz-t, . Theriault-r, . E. Singletary-s, and . D. Mcneese-m, The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy, Int J Radiat Oncol Biol Phys, issue.3, pp.50-735, 2001.

K. A. Dwamena-b, . Cronin-p, and . C. Carlos-r, Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis, Acad Radiol, vol.16, issue.5, pp.551-563, 2009.

K. T. Bauerfeind-i, . Fehm-t, . Fleige-b, . Hausschild-m, . Helms-g et al., Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicenter cohort study, Lancet Oncol, issue.7, pp.14-609, 2013.

L. C. Druet-x, D. A. Riou-o, and A. D. Bourgier-c, Quels volumes d'irradiation ganglionnaire après chimiothérapie néoadjuvante des cancers du sein ?, Cancer/Radiothérapie, vol.19, pp.271-275, 2015.

L. Scodan, R. , S. J. Stevens-d, . A. Bollet-m, . De-la-lande-b et al., Radiotherapy for Stage II and Stage III Breast Cancer Patients With Negative Lymph Nodes After Preoperative Chemotherapy and Mastectomy, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.1, pp.1-7, 2012.
DOI : 10.1016/j.ijrobp.2010.12.054

L. C. Carbone-p, T. D. Rosenbaum-p, C. W. Kline-j, . A. Steeves-r, and . Ramirez-g, Aggressive combined modality therapy for advanced local-regional breast carcinoma, J Clin Oncol, vol.2, issue.3, pp.157-163, 1984.

M. E. , A. S. Dignam-j, B. H. , J. T. Geyer-c, T. A. Jr et al., Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27, J Clin Oncol, issue.32, pp.30-3960, 2012.

M. E. , B. J. Lembersky-b, . Fehrenbacher-l, . M. Sedlacek-s, W. D. Fisher-b et al., Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28, J Clin Oncol, vol.23, pp.3686-3696, 2005.

M. L. Prosnitz-l, Reducing local therapy in patients responding to preoperative systemic therapy: are we outsmarting ourselves?, J Clin Oncol, vol.32, issue.6, pp.491-493, 2014.

M. D. and P. N. Ioannidis-j, Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis, J Natl Cancer Inst, vol.97, pp.188-194, 2005.

M. M. Houssami-n, . Macaskill-p, . Sardanelli-f, . Irwig-l, . P. Mamounas-e et al., Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy, J Natl Cancer Inst, vol.105, pp.321-333, 2013.

M. P. , T. C. Correa-c, C. D. , D. F. Ewertz-m, G. R. Mannu-g et al., Early Breast Cancer Trialists' Collaborative Group. 2014. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomized trials, Lancet, issue.9935, pp.383-2127

M. S. Gonzalez-angulo-a, T. H. Huang-e, . Kau-s-w, . Yu-t-k, O. A. Strom-e et al., Post mastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy, Int J Radiat Oncol Biol Phys, vol.68, issue.4, pp.1004-1009, 2007.

M. J. Van-der, H. J. Van-de, and . J. Velde-c, Preoperative chemotherapy for women with operable breast cancer, Cochrane Database Syst Rev, vol.27, issue.5, p.5002, 2007.
DOI : 10.1002/14651858.CD005002.pub2

M. E. Buchholz-t, T. S. Meric-bernstam, K. H. Gonzalez-angulo-a, . Bedrosian-i, . V. Babiera-g et al., Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy, Ann Surg, vol.257, issue.2, pp.173-179, 2013.

N. H. , M. E. Strom-e, O. H. Perkins-g, T. W. Woodward-w, H. M. Gonzalez-angulo-a et al., Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer, Int J Radiat Oncol Biol Phys, vol.81, issue.3, pp.782-787, 2011.

N. L. Buzdar-a, K. E. Singletary-s, . Buchholz-t, R. C. Ames-f, and . K. Hunt-k, A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility, Ann Surg Oncol, vol.9, issue.3, pp.228-234, 2002.

O. M. Hansen-p, O. J. , R. C. Andersson-m, . Bach-f, . Kjaer-m et al., Danish Breast Cancer Cooperative Group 82b Trial. 1997. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy, N Engl J Med, issue.14, pp.337-949

O. M. Jensen-m-b, O. J. Hansen-p, R. C. Andersson-m, . Kamby-c, . Kjaer-m et al., Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial, Lancet, issue.9165, pp.353-1641, 1999.

P. C. Sørlie-t, . B. Eisen-m, J. S. Van-de-rijn-m, R. C. Pollack-j, R. D. Johnsen-h et al., Molecular portraits of human breast tumors, Nature, vol.406, pp.747-752, 2000.

P. P. , C. S. Kirkove-c, . Van-limbergen-e, . Budach-v, C. L. Struikmans-h et al., EORTC Radiation Oncology and Breast Cancer Groups. 2015. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer, N Engl J Med, vol.373, issue.4, pp.317-327

R. A. , G. R. , D. N. Fowble-b, . J. Solin-l, . J. Cummings-f et al., Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group, J Clin Oncol, issue.6, pp.17-1689, 1999.

R. H. Fumoleau-p, C. J. Spielmann-m, . Delozier-t, . Serin-d, . Symann-m et al., Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial, J Clin Oncol, vol.24, pp.5664-5671, 2006.

S. A. Reichman-b, C. J. Yao-t, . Currie-v, . B. Hakes-t, G. A. Hudis-c et al., Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response, J Clin Oncol, vol.13, pp.1152-1159, 1995.

S. J. , L. Scodan-r, M. J. , and H. C. Quero-l, Place de la radiothérapie après chimiothérapie première dans le cancer du sein, Cancer Radiother, vol.18, issue.3, pp.229-263, 2014.

S. E. , K. S. Ohno-s, . F. Penault-llorca, R. E. Poortmans-p, and Z. S. Cardoso-f, Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.26, issue.5, pp.8-30

S. T. Perou, C. M. Tibshirani, R. Aas, T. Geisler, S. Johnsen et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci, vol.98, pp.10869-10874, 2001.

S. S. , V. J. , T. S. Bedrosian-i, L. F. Shaitelman-s, S. B. Caudle-a et al., Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy, Ann Surg Oncol, vol.23, issue.3, pp.749-756, 2016.

T. A. Jeong-j-h, A. S. Mamounas-e, B. J. , and D. M. Wolmark-n, Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials, J Clin Oncol, issue.21, pp.22-4247, 2004.

T. L. Offersen-b, D. H. Berg-m, . Jensen-i, . N. Pedersen-a, . J. Zimmermann-s et al., DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer, J Clin Oncol, vol.34, issue.4, pp.314-320, 2016.

V. V. Holmes-f, . S. Walters-r, . L. Theriault-r, . Esparza-l, . Fraschini-g et al., Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer, J Clin Oncol, vol.13, pp.2886-2894, 1995.

H. J. Van-der, J. J. Van-de-velde-c, . M. Tubiana-hulin, . Vandervelden-c, and . Duchateau-l, Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902, Journal of Clinical Oncology, vol.19, issue.22, pp.19-4224, 2001.
DOI : 10.1200/JCO.2001.19.22.4224

V. Nes, J. G. , P. H. Van-hezewijk-m, . T. Hille-e, C. L. Bartelink-h et al., EORTC Breast Cancer Group Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence, 2010.

V. Minckwitz, G. , U. M. , B. J. , C. S. Eidtmann-h et al., Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes, Journal of Clinical Oncology, vol.30, issue.15, pp.1796-1804, 2012.
DOI : 10.1200/JCO.2011.38.8595

W. A. Bonetti-m, G. D. Gelber-r, H. M. Castiglione-gertsch, L. J. Thürlimann-b, F. M. et al., International Breast Cancer Study Group Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII, J Clin Oncol, vol.21, issue.7, pp.1205-1213, 2003.

W. G. Zhang-j-s, . Zhang-y-j, . Zhu-y-j, . Huang-x-b, and . Guan-x-x, Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Post Mastectomy Radiotherapy, J Breast Cancer, vol.19, issue.2, pp.176-184, 2016.

W. N. , W. J. Mamounas-e, and B. J. Fisher-b, Preoperative Chemotherapy in Patients with Operable Breast Cancer: Nine-Year Results from National Surgical Adjuvant Breast and Bowel Project B-18, J Natl Cancer Inst Monogr, vol.30, pp.96-102, 2001.

W. J. Takita-c, . M. Reis-i, . Zhao-w, . Saigal-k, M. A. Wolfson-a et al., Predictors of locoregional outcome in patients receiving neoadjuvant therapy and post mastectomy radiation, Cancer, vol.119, issue.1, pp.16-25, 2013.

X. Y. Foy-m, K. D. Cox-d, and H. K. Cormier-j, Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer, Br J Surg, issue.5, pp.93-539, 2006.